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This is a cross-sectional study conducted with 228 people living with HIV/AIDS in a municipality 
in the State of São Paulo during 2007 and 2008. The aims of this study were to investigate the 
intensity of the depressive symptoms in individuals with HIV/AIDS treated at two referral units in 
Ribeirão Preto, Brazil, and to compare the quality of life with the different degrees of intensity of 
the depressive symptoms in these individuals, according to gender. Data were collected through 
individual interviews, using the Beck Depression Inventory and HIV/AIDS Targeted Quality of 
Life (HATQoL). A total of 63 (27.6%) patients with symptoms of depression (mild, moderate and 
severe) were detected. The women presented more severe symptoms of intensity of depression 
than men. Individuals with depressive symptoms presented lower scores of quality of life than 
individuals without these symptoms, with statistically significant differences between the means/
medians in most domains of the HATQoL. Healthcare professionals should offer integral care for 
people with HIV/AIDS, emphasizing the depressive symptoms.
Descriptors: HIV Infections; Depression; Quality of Life.
1 RN, Ph.D. in Nursing, Professor, Escola de Enfermagem de Ribeirão Preto, Universidade de São Paulo, WHO Collaborating Centre for Nursing 
Research Development, SP, Brazil. E-mail: rkreis@eerp.usp.br.
2 Phycisist, Ph.D. in Sciences. E-mail: vjhaas@uol.com.br.
3 Ph.D. in Statistics, Associate Professor, Escola de Enfermagem de Ribeirão Preto, Universidade de São Paulo, WHO Collaborating Centre for 
Nursing Research Development, SP, Brazil. E-mail: cbsantos@eerp.usp.br.
4 RN, Ph.D. in Parasite Biology, Professor, Faculdade de Enfermagem, Universidade Federal de Goiás, Goiânia, GO, Brazil. E-mail: 
sheilaa@terra.com.br.
5 RN, Ph.D. in Tropical Diseases, Adjunct Professor, Universidade Federal do Ceará, Fortaleza, CE, Brazil. E-mail: mgalvao@gmail.com.
6 RN, Ph.D. in Nursing, Full Professor, Escola de Enfermagem de Ribeirão Preto, Universidade de São Paulo, WHO Collaborating Centre for 
Nursing Research Development, SP, Brazil. E-mail: egir@eerp.usp.br.
875
www.eerp.usp.br/rlae
Sintomas de depressão e qualidade de vida de pessoas vivendo com 
HIV/aids
Trata-se de estudo de corte transversal, realizado com amostra composta por 228 
pessoas vivendo com HIV/AIDS, em um município paulista, durante 2007 e 2008. Os 
objetivos foram investigar a intensidade dos sintomas de depressão em indivíduos com 
HIV/AIDS, atendidos em duas unidades de referência, em Ribeirão Preto, SP, e comparar 
a qualidade de vida aos diferentes graus de intensidade dos sintomas de depressão 
nesses indivíduos, segundo o gênero. Os dados foram coletados por meio de entrevistas 
individuais, utilizando-se o inventário de depressão de Beck e HIV/AIDS Targeted Quality 
of Life (HATQoL). Detectou-se 63 (27,6%) indivíduos com sintomas de depressão (leve, 
moderada e grave). As mulheres apresentaram sintomas de intensidade mais grave 
de depressão do que os homens. Indivíduos com sintomas depressivos apresentaram 
menores escores de qualidade de vida do que indivíduos com ausência desses sintomas, 
com diferenças estatisticamente significativas entre os valores médios/medianos, na 
maioria dos domínios do HATQoL. Profissionais de saúde devem oferecer assistência 
integral às pessoas com HIV/AIDS, valorizando os sintomas depressivos.
Descritores: Infecções por HIV; Depressão; Qualidade de Vida.
Síntomas de depresión y calidad de vida de personas viviendo con 
HIV/Sida
Se trata de un estudio de corte transversal realizado en 228 personas viviendo con 
HIV/Sida en un municipio del estado de Sao Paulo, durante 2007 y 2008. Los objetivos 
fueron investigar la intensidad de los síntomas de depresión en individuos con HIV/Sida 
atendidos en dos unidades de referencia en Ribeirao Preto, SP, y comparar la calidad 
de vida con los diferentes grados de intensidad de los síntomas de depresión en esos 
individuos, según el género. Los datos fueron recolectados por medio de entrevistas 
individuales, utilizando el Inventario de Depresión de Beck y HIV/AIDS Targeted Quality 
of Life (HATQoL). Se detectaron 63 (27,6%) individuos con síntomas de depresión (leve, 
moderado y grave). Las mujeres presentaron síntomas de intensidad más grave de 
depresión que los hombres. Individuos con síntomas depresivos presentaron menores 
puntajes de calidad de vida que individuos con ausencia de esos síntomas, con diferencias 
estadísticamente significativas entre los valores medios/medianos en la mayoría de los 
dominios del HATQoL. Los profesionales de la salud deben ofrecer asistencia integral a 
las personas con HIV/Sida, valorizando los síntomas depresivos.
Descriptors: Infecciones por VIH; Depresión; Calidad de Vida.
Introduction
Quality of life (QoL) has become one of the major 
goals in studies regarding infection with the human 
immunodeficiency virus (HIV), because, due to advances 
in the treatment with the use of antiretrovirals, there 
has been a decrease of opportunistic infections, and an 
increase in the rates of survival(1). Given the change in the 
course of HIV infection to a chronic disease, improving 
the quality of life of people living with HIV/AIDS became 
one of the major goals of clinical practice and research in 
the area(2). Studies of QoL among people living with HIV/
AIDS indicate that this is affected by many individual, 
cultural, social and emotional factors, related to the 
impact of the diagnosis and the treatment and quotidian 
living with a chronic disease(3). Different variables, 
such as gender, living and health conditions, have been 
studied for their relationship with QoL, however, some 
authors have shown that depression significantly affects 
all the QoL dimensions evaluated(4-5).
Depression is a common condition experienced by 
people living with chronic conditions, causing disability, 
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affecting the evolution of the disease and interfering 
in the recovery and is considered a potential risk for 
increased morbidity and mortality for many medical 
conditions, including HIV/AIDS(6). HIV infection and 
psychiatric disorders present a complex relationship 
and have received special attention in the last decade, 
considering their impact in the personal, sexual, social 
and occupational lives of people living with HIV/AIDS(7). 
Among the various psychiatric disorders frequently 
identified in people living with HIV/AIDS, depression 
is the most prevalent. Apart from depression, it has 
been observed that stressful life events are associated 
with increased progression of the HIV/AIDS infection(8), 
which in turn, increase from three to five times the risk 
of developing depression(9).
It has been well established that HIV/AIDS infection 
compromises the quality of life of the sufferer(10). 
However, other authors highlight a close relationship 
between depression and quality of life(5), especially in 
individuals with chronic diseases(11). Considering that 
AIDS is a chronic disease and that its sufferers have a 
high risk of developing depressive symptoms, which has 
been associated with a decrease in the quality of life, the 
aims of this study were to investigate the intensity of 
the depressive symptoms in individuals with HIV/AIDS 
treated at two referral units in Ribeirao Preto, Brazil, and 
to compare the quality of life with the different degrees 
of intensity of depressive symptoms in these individuals, 
according to gender.
Method
This is a cross-sectional quantitative study, 
conducted at two services specializing in outpatient 
clinical care for people living with HIV/AIDS, located in 
the municipality of Ribeirão Preto-SP. These services 
have 500 registered patients, of these 228 (45.6%) 
participated in the study. The study included individuals 
aged at least 18 years; HIV positive; with clinical and 
emotional conditions to respond to the questionnaires; 
having been attended at least once in the services 
participating in the study in the period from March 2007 
to March 2008.
For the data collection, an individual interview was 
initially performed in rooms in the outpatient clinic, 
using a semi-structured script, developed specifically 
for this study, referring to sociodemographic data, age 
in years, gender (male, female), marital status (single, 
married, separated, widowed, living with partner, 
divorced) schooling in years of study, family income (in 
minimum wages), employment contract (yes, no, retired, 
unemployed). Next the Beck Depression Inventory (BDI) 
was applied to assess the intensity of the depressive 
symptoms and, finally, the HATQoL (HIV/AIDS Targeted 
Quality of Life) instrument to evaluate the quality of life 
of the participants. Several instruments are available to 
investigate the intensity of depressive symptoms, with 
the Beck Depression Inventory (BDI) one of the most 
used and translated into several languages (12). The BDI 
is a self-administered scale, translated and validated in 
Brazil(13) and is composed of 21 items that contemplate 
cognitive depressive symptoms and attitudes.
The score for each category of the BDI ranges from 
zero to three, where zero corresponds to the absence of 
depressive symptoms and three to the presence of more 
intense symptoms. For the total score, up to 15 points 
signifies the absence or minimal presence of depressive 
symptoms, between 16 and 20 points there is evidence 
of depressive symptoms of mild to moderate intensity, 
and above 20 points indicates depressive symptoms of 
moderate to severe intensity. A score of 30 to 63 points 
indicates depressive symptoms of severe intensity. There 
are different cutoff points for depression, depending on 
the nature of the sample and the aims of the study. Also 
for undiagnosed samples, the guidelines are different, 
with scores greater than or equal to 18 giving an 
estimate of possible depression(13). In this study the 
categorization was used in which obtaining 21 points or 
more, could be considered as the presence of clinically 
significant depression(14).
The HATQoL is a specific instrument, translated and 
validated in Brazil(15), for the evaluation of the quality 
of life of people living with HIV/AIDS. This instrument 
consists of 42 items divided into nine dimensions 
(Overall Function, Sexual Function, Disclosure Worries, 
Health Worries, Financial Worries, HIV Mastery, Life 
Satisfaction, Medication Worries and Provider Trust). This 
instrument was originally constructed from the personal 
suggestions of people living with HIV/AIDS, which 
implies that it evaluates domains that are important 
for this population(16). To answer each question, the 
individuals are compelled to think about their quality 
of life in the last four weeks. The answers are in the 
format of a Likert type scale of five points: “All the time”, 
“most of the time”, “part of the time”, “a few times” and 
“never”. In each domain, zero is the lowest score and 
100 the best score possible. The higher the score, the 
lower the impact of the HIV infection on the quality of life 
of the individuals. In other words, the lower the score, 
the more affected the function, the greater the concern 
and the lower the life satisfaction(15). Regarding the 
psychometric properties of the instrument, the Brazilian 
Portuguese version of the HATQoL was shown to be 
comprehensible and easily applied, with good construct 
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validity and excellent reliability. Excellent results were 
found for the internal consistency, with Cronbach’s 
alphas always above the cutoff value (0.70)(16). The 
authors highlight that this instrument can contribute to 
the evaluation of quality of life in the population with 
HIV/AIDS in Brazil.
For the analysis, the data were initially organized in 
an Excel spreadsheet, double entered and validated in 
order to obtain reliable data, free of transcription errors. 
Next, the data were exported into the statistical analysis 
program Statistical Package for the Social Sciences 
(SPSS) version 15.0. The Kolmogorov-Smirnov test was 
conducted to evaluate the normality of distributions 
of sample means of the scores of the domains of the 
QoL measurement. To analyze statistically significant 
differences between the means or medians of the quality 
of life scores in the different intensity of depressive 
symptoms groups, the ANOVA and Kruskal-Wallis 
tests were used. The Chi-square test was performed 
to verify the association between intensity of the 
depressive symptoms and gender. The descriptive level 
of significance used was 0.05 (α=0.05).
The confidentiality of all the participants and the 
anonymity of the information were guaranteed and the 
data were collected with the consent of the participants, 
who all signed the Terms of Free Prior Informed Consent. 
The study was approved by the Ethics Committee of 
the University of São Paulo at Ribeirão Preto College of 
Nursing, according to protocol No. 0699/2006.
Results
The sociodemographic profile of the individuals 
studied is presented in Table 1. Regardless of gender, 
almost half of the individuals were less than 40 years 
of age.
Table 1 - Distribution of the study participants, according to sociodemographic variables. Ribeirão Preto-SP, 2007 - 
2008
Variables
Male Female Total
n % n % n %
Age (years)       
20 to 29 16 13.1 9 8.5 25 11.0
30 to 39 51 41.8 47 44.3 9 43.0
40 to 49 34 27.9 32 30.2 66 28.9
50 to 59 17 13.9 16 15.1 33 14.5
≥60 4 3.3 2 1.9 6 2.6
Marital status       
Single 72 59 32 30.2 104 45.6
Living with partner 18 14.8 29 27.4 47 20.6
Married 19 15.6 19 17.9 38 16.7
Separated 7 5.7 7 6.6 14 6.1
Widowed 1 0.8 12 11.3 13 5.7
Divorced 5 4.1 7 6.6 12 5.3
Schooling       
Illiterate 4 3.3 8 7.5 12 5.3
Incomplete Elementary Education 49 40.2 57 53.8 106 46.5
Complete Elementary Education 17 13.9 23 21.7 40 17.5
Complete High School Education 41 33.6 16 15.1 57 25.0
Complete Higher Education 11 9.0 2 1.9 13 5.7
Income (minimum wage)       
No income 13 10.7 18 17.0 31 13.6
≤ 1 12 9.8 35 33.0 47 20.6
1.1 to  3 69 56.6 49 46.2 118 51.8
3.1 to 5 17 13.9 3 2.8 20 8.8
> 5 11 9.0 1 0.9 12 5.3
Employment contract       
No 42 34.4 55 51.9 97 42.5
Yes 48 39.3 33 31.1 81 35.5
Unemployed 16 13.1 13 12.3 29 12.7
Retired 16 13.1 5 4.7 21 9.2
* the minimum monthly wage during the study period was R$ 380.00 (three hundred and eighty reais)
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The evaluation using the Beck Depression Inventory 
identified that 63 (27.6%) individuals presented 
symptoms of depression; being 13 (5.7%) with mild 
symptoms, 29 (12.7%) with moderate and 21 (9.2%) 
with severe symptoms. When comparing the presence of 
depressive symptoms between the genders, statistically 
significant differences were verified between men and 
women, since the women presented symptoms of a more 
severe intensity of depression than the men (Table 2).
Table 2 - Distribution of the participants of the study according to intensity of depressive symptoms, according to the 
Beck Depression Inventory and gender and the value of the statistical significance p associated with the Chi-square 
test. Ribeirão Preto-SP, 2007 - 2008
Symptoms of Depression
Male Female Total
χ2 p
n % n % n %
Absent (≤15)* 97 79.5 68 64.0 165 72.4
12.1 <0.01
Mild (16 to 20) 7 5.7  6 6.0 13 5.7
Moderate (>20 to 29) 14 11.5 15 14.0 29 12.7
Severe (>30) 4 3.3 17 16.0 21 9.2
Total 122 100 106 100 228 100
* BDI Score
Regarding the quality of life domains of the HATQoL, 
when compared with symptoms of depression in the 
individuals investigated, an inverse relationship was 
identified, i.e. the greater the intensity of symptoms, the 
worse the QoL in most domains except in the domains 
“Disclosure Worries” and “Provider Trust” in which no 
statistically significant associations were identified 
(Table 3).
Table 3 - Standardized values  of means and medians of the domains of the HATQoL scale in the study participants, 
according to intensity of depressive symptoms and their statistical significance values p,  associated with the ANOVA 
or Kruskal-Wallis test. Ribeirão Preto-SP, 2007 - 2008
Domains of the HATQoL
Depressive Symptom
pAbsent  Mild to moderate Severe
Mean/Median Mean/Median Mean/Median
Overall Function 81.8/89.3 57.0/55.4 45.9/39.3 <0.001
Sexual Function 68.4/75.0 51.4/50.0 40.5/50.0 <0.001
Disclosure Worries 31.5/25.0 30.5/20.0 35.5/40.0 0.826
Health Worries 58.2/60.0 29.5/27.5 27.6/25.0 <0.001
Financial Worries 36.9/31.2 24.7/12.5 15.5/6.2 <0.001
HIV Mastery 71.8/66.7 58.7/58.3 46.4/33.3 <0.001
Life Satisfaction 78.5/78.1 55.1/57.8 37.8/31.2 <0.001
Medication Worries 86.5/93.7 74.3/75.0 67.9/65.6 <0.001
 Provider Trust 96.7/100 92.5/100 95.2/100 0.103(a)
(a) Kruskal-Wallis test
Discussion
The results of this study indicate a prevalence of 
depressive symptoms of 27.6% according to the BDI. 
However, it was evident that, when comparing the 
presence of depressive symptoms between the genders, 
statistically significant differences were verified between 
men and women, since the women presented symptoms 
of a more severe intensity of depression than the men. 
Another study in Brazil also indicated a high prevalence of 
25.8% of symptoms of depression among women infected 
by HIV/AIDS, much higher values  when compared with 
the general female population(9). These results indicate 
the necessity of comprehending the factors that increase 
the risk of depression among women, considering that 
rates of depression in the world vary from 4% to 10% 
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in the general population, however, throughout life, the 
prevalence of depression among women is higher than 
among men, with rates varying from 10% to 25% in 
women and 5% to 12% in men(17).
It is estimated that depression affects 22% to 45% 
of people with HIV/AIDS(17), with social and psychological 
factors, such as difficulties in emotional and sexual 
relationships, marital conflict and social exclusion having 
been suggested as possible causes of depression in the 
HIV seropositive population(8). Moreover, depression 
has been associated with alterations in immunological 
function, with decreases in the activity of Natural Killer 
cells and CD8 lymphocytes(8) impacting the progression 
of the HIV infection(6). Nevertheless, the diagnosis and 
treatment of depression in people living with HIV/AIDS 
occur in only 40% to 50% of the cases(11). The variability 
observed between the rates reported in the literature 
can be attributed to factors such as the instrument used 
and the characteristics of the study population, the 
location in which the research was performed and the 
stage of disease(18).
Depression is one of the most prevalent and least 
diagnosed psychiatric disorders among individuals living 
with HIV/AIDS, and when compared to the general 
population is significantly higher in these individuals(19), 
with rates approximately twice as high(20). The data also 
confirm the negative impact of depression in all domains 
of the HATQoL, except in the domains and Provider trust 
and Disclosure worries. It was observed that the greater 
the intensity of the depressive symptoms the worse the 
QoL scores. Studies carried out in Porto Alegre-RS with 
the population treated at a primary care unit and with 
people living with HIV/AIDS also found similar results, 
showing that the presence of depressive symptoms 
seems to negatively affect the quality of life in many of 
the evaluated dimensions(5,21). The association between 
depression and viral infection is not new(22), however, 
in Brazil, studies that evaluate the relationship between 
quality of life and depressive symptoms are still very 
incipient(23).
Other studies performed in Brazil show that the 
quality of life of people living with HIV/AIDS is related 
to many variables(5,15). There is significant evidence in 
the literature that the depressed individuals presented 
significant impairment in quality of life and physical 
and mental functioning, considering that depressive 
disorders affect many domains of the overall evaluation 
of quality of life(4), considered one of the strongest 
predictors of lower quality of life of people with HIV/
AIDS. Other authors also highlight that depression has 
a negative impact on all the dimensions of quality of 
life studied, in addition to being associated with poor 
adherence to the antiretroviral treatment(24), and a 
greater perception of the stigma associated with HIV(25). 
Depression negatively impacts the quality of life in 
different populations with chronic disease(26). Depressive 
disorders complicate the course of any disease through 
a variety of mechanisms, which increase the pain, 
interfere in the adherence to treatment, decrease social 
support and disrupt the humoral and cell-mediated 
immunological systems. Individuals with chronic disease 
who are depressed present more disability than those 
who are not depressed(27).
Depressive disorders are associated with serious 
consequences in terms of mortality and morbidity, causing 
loss of productivity and interfering in interpersonal 
relationships. The long-term effects of depression are 
as severe as those observed in diverse general medical 
conditions, and are likely to have adverse effects 
on longevity and well-being(5). However, despite the 
negative impact of depression for the progression of HIV/
AIDS and in the quality of life of people living with HIV/
AIDS, the diagnosis and treatment do not occur in 50% 
to 60% of the cases(12). The diagnosis of depression can 
often be difficult due to the imprecise boundary between 
its manifestations in clinical and subclinical forms, 
especially in individuals with HIV. In these individuals, 
the difficulties in the diagnosis of depression become 
more severe, given that clinical conditions common in 
depression, such as fatigue, decreased appetite, sleep 
disturbance and weight loss, are frequently found in 
individuals living with HIV/AIDS(28). In addition, there 
are other barriers for the diagnosis of depression among 
HIV-infected individuals, including the difficulty for 
the individual to talk about their emotions with health 
professionals and the comprehension by the health 
professionals that depression is a normal reaction arising 
from HIV seropositivity(29).
Given the impact of the antiretrovirals on the 
survival of those infected by HIV/AIDS, the adherence 
to the treatment is the center of the interventions of 
the professionals. While medical treatment has been 
making undeniable progress, the emotional support that 
encourages better confrontation of the emotional issues, 
fundamental to self-care, still suffers the consequences 
of the professionals being unprepared to address the 
psychosocial aspects that arise from HIV seropositivity(29). 
In this sense, it is essential that clinicians, nurses, 
psychologists and other health professionals comprehend 
and identify the associated factors and the determinants 
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of depression in the context of HIV/AIDS infection, given 
its impact on the quality of life of HIV seropositive people 
with depressive symptoms.
Final considerations
To describe the intensity of symptoms of depression 
and their relationship with gender and with the domains 
of quality of life in the population infected by HIV/AIDS 
are important steps to develop therapeutic interventions 
and psychosocial support for these individuals, directed 
not only towards the treatment, but towards the 
prevention of depressive episodes, considering the high 
prevalence of depression and its consequences on the 
quality of life of HIV-infected individuals, as well as its 
impact on the evolution of the HIV infection. Health 
professionals should be aware of this issue, aiming to 
promote the mental health of the people living with HIV/
AIDS. In this sense the nurse exercises a fundamental 
role and can help the healthcare team in the prevention, 
diagnosis and treatment of this important morbidity 
among people with HIV/AIDS, as well as in the provision 
of integral care to these individuals.
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